Anti-α-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event

Por Freedman, MS, Laks, J, Dotan, N, Altstock, RT, Dukler, A, Sindic, CJM
Publicado em 2009

Antibodies against Glucan, Chitin, and Saccharomyces cerevisiae Mannan as New Biomarkers of Candida albicans Infection That Complement Tests Based on C. albicans Mannan

Por Sendid, B., Dotan, N., Nseir, S., Savaux, C., Vandewalle, P., Standaert, A., Zerimech, F., Guery, B. P., Dukler, A., Colombel, J. F., Poulain, D.
Publicado em 2008

Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis

Por Freedman, MS, Metzig, C, Kappos, L, Polman, CH, Edan, G, Hartung, H-P, Miller, DH, Montalban, X, Yarden, J, Spector, L, Fire, E, Dotan, N, Schwenke, S, Lanius, V, Sandbrink, R, Pohl, C
Publicado em 2012